Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
Autor: | Oh, Do-Youn *, Lee, Kyung-Hun, Lee, Dae-Won, Yoon, Jeesun, Kim, Tae-Yong, Bang, Ju-Hee, Nam, Ah-Rong, Oh, Kyoung-Seok, Kim, Jae-Min, Lee, Young, Guthrie, Violeta, McCoon, Patricia, Li, Weimin, Wu, Song, Zhang, Qu, Rebelatto, Marlon C, Kim, Jin Won |
---|---|
Zdroj: | In The Lancet Gastroenterology & Hepatology June 2022 7(6):522-532 |
Databáze: | ScienceDirect |
Externí odkaz: |